bio CDMO
Scope
Date
~
-
Mergers & Acquisitions
CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
CJ CheilJedang Corp., South Korea’s largest food and beverage company, said on Wednesday it has scrapped a planned sale of its green bio busin...
16 HOURS AGO
-
Bio & Pharma
ABL Bio lands $2.8 billion license-out deal with GSK
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...
Apr 07, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business
North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other conten...
Mar 06, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
MBK Partners, 2 Chinese firms vie for CJ Cheiljedang’s $4 bn bio business
North Asia-focused private equity firm MBK Partners and two leading Chinese biotechnology firms are vying for management control of CJ Cheiljedang C...
Feb 13, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Jan 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion BioSolutions launched to venture into CDMO
Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...
Dec 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Dec 12, 2024 (Gmt+09:00)
-
Chemical Industry
HD Hyundai Oilbank supplies bio VLSFO to Yangming
HD Hyundai Oilbank Co., a South Korean crude oil refiner backed by Saudi Aramco, said on Thursday it started to supply Taiwan-based Yang Ming Marine...
Dec 12, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone, Carlyle, MBK vying for CJ CheilJedang’s bio business
Blackstone, Carlyle Group and MBK Partners have joined the race to purchase the bio business of CJ CheilJedang Corp., the world’s largest prod...
Dec 02, 2024 (Gmt+09:00)
-
Business & Politics
Latvian President Rinkēvičs seeks closer ties with S.Korea in bio, defense
Latvian President Edgars Rinkēvičs, who is on a four-day working trip to South Korea, said on Friday he hopes for deeper cooperation between the two...
Nov 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to break ground on CDMO plant in 2025: Chairman Seo
South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...
Nov 28, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
CJ CheilJedang puts bio business on market for $4 bn
CJ CheilJedang Corp., South Korea’s largest food company, is seeking to sell its bio business for about 6 trillion won ($4.3 billion) in what ...
Nov 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Oct 18, 2024 (Gmt+09:00)
-
Chemical Industry
LG Chem targets functional cosmetics market with bio-materials
LG Chem Ltd., the world’s fourth-largest chemicals manufacturer, is targeting the functional cosmetics market with bio-materials derived from ...
Oct 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Sep 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte to restructure bio business to focus on CDMO
South Korea’s retail-to-chemical conglomerate Lotte Group will restructure its bio business to focus on the profit-making medicine bio develop...
Sep 09, 2024 (Gmt+09:00)
-
KOREA Investment Week
Korea's investment forum KIW 2024 kicks off September 9
South Korea’s largest investment forum Korea Investment Week 2024 (KIW 2024) will kick off next month in Seoul, drawing around 150 leaders fro...
Aug 12, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Petrochemicals
HD Hyundai Oilbank exports bio marine fuel blends
The Korea Customs Service announced on July 29 that domestic petroleum products were exported after being blended in a bonded zone for the first tim...
Jul 30, 2024 (Gmt+09:00)
-
Artificial intelligence
LG to foster smart factory business as new B2B growth driver
PYEONGTAEK, Gyeonggi Province -- LG Electronics Inc., the leading global home appliance maker, aims to foster its smart factory business as a new gr...
Jul 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Elec invests in US bio startup Element Biosciences
Samsung Electronics Co., the world’s top memory chipmaker, said on Friday it has invested in US biotech startup Element Biosciences Inc. to ex...
Jul 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung to invest $52 mn in US biotech VC Flagship Pioneering
Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...
Jul 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...
Jul 03, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
SK Inc., the holding and investment company of SK Group, South Korea’s second-largest conglomerate, is negotiating to sell a major asset of it...
Jun 25, 2024 (Gmt+09:00)
-
Leadership & Management
PwC's Korean member taps new chiefs, creates finance unit
Samil PricewaterhouseCoopers (PwC), a South Korean member firm of PwC International Ltd., has appointed new chiefs of its key units and created a fi...
Jun 17, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand